PROGRAMS AND SERVICES
Kadmon ASSIST offers coverage verification, financial assistance and patient support services for eligible patients. Explore our list of programs and services below.
INSURANCE
A Kadmon ASSIST Case Manager will review patients’ insurance coverage, discuss with patients the programs that are available to them and assist with the prior authorization (PA) or the medical exception/appeals process.
Kadmon ASSIST will help to gather relevant nonclinical information to support the completion and submission of a PA/Nonformulary Exception (NFE) form. If the PA/NFE form is denied, Kadmon ASSIST will offer assistance with appeals. Upon PA approval, a Kadmon ASSIST Case Manager will follow up with the provider to address any outstanding questions or concerns they may have.
Institutions seeking Kadmon ASSIST PA/appeals assistance are offered the option to have their prescription returned once approved so they can dispense product directly to patients.
ACCESS
- Patients must be enrolled in Kadmon ASSIST and provide consent
- Patients must be new to therapy (initial fill) with REZUROCK
- Patients must have a valid prescription for REZUROCK with on-label diagnosis
- Patients must reside in the United States or its territories
- Patients must have prescription drug coverage
- Patients must have a coverage barrier, such as a PA, in obtaining their treatment that will take longer than 5 business days
The Quick Start Program delivers a free 30-day supply of REZUROCK® (belumosudil) tablets to eligible patients who are experiencing a delay in their coverage decision for their first REZUROCK prescription.
Eligibility criteria
- Patients must be enrolled in Kadmon ASSIST and provide consent
- Patients must already be on therapy with REZUROCK and face an interruption in insurance coverage
- Patients must have a valid prescription for REZUROCK with on-label diagnosis
- Patients must be commercially or privately insured
- Patients must reside in the United States or its territories
- Patients must have a coverage barrier, such as a PA, change in insurance status, job change or extended foreign travel, in obtaining their treatment
The Bridge Program delivers a free 30-day supply of REZUROCK to eligible patients who are facing an interruption in their insurance coverage.
Eligibility criteria
- Patients must be enrolled in Kadmon ASSIST and provide consent
- Patients must provide proof of income and out-of-pocket expenses
- Patients must have a valid prescription for REZUROCK with on-label diagnosis
- Patients must reside in the United States or its territories
- Patients must be uninsured or underinsured
- Patients must meet additional income criteria and program requirements
The Kadmon ASSIST PAP helps eligible patients who do not have insurance coverage or who have trouble affording REZUROCK. Through the PAP, patients may be eligible to receive a free supply of REZUROCK for up to 12 months.
Eligibility criteria
Kadmon ASSIST will help identify a specialty pharmacy within the REZUROCK network and help coordinate product shipment to a preferred address.
Patients who are not eligible for any affordability programs through Kadmon ASSIST may be referred to an independent charitable foundation for assistance.
All patients are eligible for benefits investigation and verification services, as well as adherence support.
CO-PAY
- Patients must be commercially or privately insured
- Patients enrolled in a state- or federally funded insurance program are not eligible (eg, Medicare Part D, Medicaid, TriCare)
- Cash-paying patients are not eligible
- Patients must have a valid prescription for REZUROCK with on-label diagnosis
- Patients must be a resident of the United States or its territories
- Patients must be aged ≥12 years
Eligible patients with commercial or private insurance pay as low as $0 per month for their REZUROCK prescription.a
Eligibility criteria
Enroll an eligible patient in the Commercial Co-pay Savings Program
aPatient Terms and Conditions: The Kadmon ASSIST Commercial Co-pay Savings Program provides co-pay/coinsurance support for out-of-pocket costs on REZUROCK® (belumosudil) tablets prescriptions. A yearly maximum benefit applies. Limit one 30-day supply per 30 days. This program is not health insurance. This program is for commercially or privately insured patients only; uninsured or cash-paying patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state- or federally funded programs, including, but not limited to, Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, TriCare, private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. The co-pay program may not be combined with any other rebate, coupon or offer. Kadmon Pharmaceuticals, LLC, reserves the right to rescind, revoke or amend this offer at any time without further notice. Any savings provided by the co-pay program may vary depending on patients' out-of-pocket costs. Card is valid through December 31 of the year of activation. On January 1 of the following year, the card automatically resets and is subject to annual limits if the prescription benefit remains the same. Upon registration, patients receive all program details.
EDUCATION
All eligible patients enrolled in Kadmon ASSIST will receive a Patient Starter Kit with their first prescription of REZUROCK, which includes disease information and treatment education. Kadmon ASSIST Case Managers will connect eligible patients with an adherence nurse who can answer their questions about REZUROCK.b
bKadmon does not provide medical advice, diagnosis, or treatment recommendations.
PROGRAM ENROLLMENT FORM
Find out which services patients may be eligible for by completing this form. Our Kadmon ASSIST Case Managers can determine which programs are available to patients.
ENROLL FOR CO-PAY SUPPORT
For eligible patients with commercial or private insurance plans.
CONTACT US
Our Kadmon ASSIST team is available to help you Monday through Friday, 8 AM-8 PM ET.
Phone: 1-844-KADMON1 (523-6661)
Fax: 1-833-635-1481